Canada markets open in 7 hours 17 minutes

Agios Pharmaceuticals, Inc. (AGIO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
33.19-1.15 (-3.35%)
At close: 04:00PM EDT
32.54 -0.65 (-1.96%)
After hours: 04:58PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.88B
Enterprise Value 1.35B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)63.13
Price/Book (mrq)2.53
Enterprise Value/Revenue 46.07
Enterprise Value/EBITDA -1.33

Trading Information

Stock Price History

Beta (5Y Monthly) 0.81
52-Week Change 322.38%
S&P500 52-Week Change 328.04%
52 Week High 335.50
52 Week Low 319.80
50-Day Moving Average 330.94
200-Day Moving Average 326.12

Share Statistics

Avg Vol (3 month) 3734.07k
Avg Vol (10 day) 3595.58k
Shares Outstanding 556.77M
Implied Shares Outstanding 656.77M
Float 847.41M
% Held by Insiders 11.46%
% Held by Institutions 1110.59%
Shares Short (Apr 30, 2024) 46.51M
Short Ratio (Apr 30, 2024) 49.77
Short % of Float (Apr 30, 2024) 411.62%
Short % of Shares Outstanding (Apr 30, 2024) 411.46%
Shares Short (prior month Mar 28, 2024) 46.6M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,124.34%

Management Effectiveness

Return on Assets (ttm)-24.55%
Return on Equity (ttm)-39.61%

Income Statement

Revenue (ttm)29.4M
Revenue Per Share (ttm)0.53
Quarterly Revenue Growth (yoy)46.00%
Gross Profit (ttm)N/A
EBITDA -386.76M
Net Income Avi to Common (ttm)-352.62M
Diluted EPS (ttm)-6.31
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)597.99M
Total Cash Per Share (mrq)10.53
Total Debt (mrq)68.35M
Total Debt/Equity (mrq)9.19%
Current Ratio (mrq)12.84
Book Value Per Share (mrq)13.11

Cash Flow Statement

Operating Cash Flow (ttm)-300.75M
Levered Free Cash Flow (ttm)-221.81M